• ISSN : 2231 - 0541 (Online)
  • 0976 - 3090 (print)
  • NLM ID : 101613942
  • CAS CODEN : PHARN8
  • Frequency : Bi-Monthly

ATTENTION-DEFICIT /HYPERACTIVE DISORDER - IS A “REAL” DISEASE?

ATTENTION-DEFICIT /HYPERACTIVE DISORDER - IS A “REAL” DISEASE?

Attention-deficit/hyperactivity disorder (AD/HD or ADHD) is neurobehavioral developmental disorder. It affects about 3 to 5% of children globally with symptoms starting before seven years of age. There is wide variability in estimates dependenting on research methodologies utilized in studies. It is characterized by a persistent pattern of impulsiveness and inattention, with or without a component of hyperactivity. ADHD is generally a chronic disorder with 30 to 50% of individuals diagnosed in childhood continuing to have symptoms into adulthood. As they mature, adolescents and adults with ADHD are likely to develop coping mechanisms to compensate for their impairment. Better methods are needed for monitoring the prevalence and understanding the public health implications of ADHD. Stimulant medication is the treatment of choice for treating ADHD but psychosocial interventions may also be warranted if comordid disorders are present. Pharmacologic treatments and multiple types of psychotherapy are available for adults with ADHD.